Hayashi M
Environ Res. 1983 Feb;30(1):152-60. doi: 10.1016/0013-9351(83)90174-3.
A study was made of the effects of administration of 500 ppm of lead in the drinking water of pregnant rats and their fetuses. The delta-aminolevulinic acid dehydratase (ALAD) activity of erythrocytes in lead-treated dams showed 82.7 and 74.8% inhibition on Days 18 and 21 of pregnancy, respectively. ALAD activity of erythrocytes in the lead-treated fetuses showed 59.7 and 73.0% inhibition on Days 18 and 21 of pregnancy, respectively. ALAD activities in the liver and placenta were not significantly different between the lead-treated and control animals. The lead concentrations of blood and liver in the lead-treated dams and fetuses were higher than in the control animals, but the lead level of amniotic fluid was not significantly different from that of the control animals. Significant correlations were observed between maternal and fetal blood lead, liver lead, and erythrocyte ALAD, but there was no significant correlation between maternal and fetal liver ALAD.
对怀孕大鼠及其胎儿饮用含500 ppm铅的水的影响进行了一项研究。在怀孕第18天和第21天,接受铅处理的母鼠红细胞中的δ-氨基乙酰丙酸脱水酶(ALAD)活性分别受到82.7%和74.8%的抑制。在怀孕第18天和第21天,接受铅处理的胎儿红细胞中的ALAD活性分别受到59.7%和73.0%的抑制。接受铅处理的动物与对照动物的肝脏和胎盘中的ALAD活性没有显著差异。接受铅处理的母鼠和胎儿的血液及肝脏中的铅浓度高于对照动物,但羊水的铅水平与对照动物没有显著差异。在母鼠和胎儿的血铅、肝铅及红细胞ALAD之间观察到显著相关性,但母鼠和胎儿肝脏ALAD之间没有显著相关性。